Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 17 results:
Author Title [ Type(Desc)] Year
Filters: Author is Hennessy, S.  [Clear All Filters]
Journal Article
B. L. Strom, Schinnar, R., Apter, A. J., Margolis, D. J., Lautenbach, E., Hennessy, S., Bilker, W. B., and Pettitt, D., Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics, N Engl J Med, vol. 349, pp. 1628-35, 2003.
S. B. Meropol, Chan, K. A., Chen, Z., Finkelstein, J. A., Hennessy, S., Lautenbach, E., Platt, R., Schech, S. D., Shatin, D., and Metlay, J. P., Adverse events associated with prolonged antibiotic use, Pharmacoepidemiol Drug Saf, vol. 17, pp. 523-32, 2008.
J. H. Flory, Ellenberg, S., Szapary, P. O., Strom, B. L., and Hennessy, S., Antidiabetic action of bezafibrate in a large observational database, Diabetes Care, vol. 32, pp. 547-51, 2009.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sedarat, A., and Lewis, J. D., Chronic proton pump inhibitor therapy and the risk of colorectal cancer, Gastroenterology, vol. 133, pp. 748-54, 2007.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sarkar, M., and Lewis, J. D., Chronic statin therapy and the risk of colorectal cancer, Pharmacoepidemiol Drug Saf, vol. 17, pp. 869-76, 2008.
S. Hennessy, Bilker, W. B., Knauss, J. S., Kimmel, S. E., Margolis, D. J., Morrison, M. F., Reynolds, R. F., Glasser, D. B., and Strom, B. L., Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol, Br J Clin Pharmacol, vol. 58, pp. 81-7, 2004.
M. E. Saine, Carbonari, D. M., Newcomb, C. W., Gallagher, A. M., Blak, B. T., Roy, J. A., Wood, J., Cardillo, S., Hennessy, S., Strom, B. L., and , Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies, Pharmacoepidemiol Drug Saf, 2019.
M. E. Saine, Carbonari, D. M., Newcomb, C. W., Nezamzadeh, M. S., Haynes, K., Roy, J. A., Cardillo, S., Hennessy, S., Holick, C. N., Esposito, D. B., Gallagher, A. M., Bhullar, H., Strom, B. L., and , Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs, BMC Pharmacol Toxicol, vol. 16, p. 8, 2015.
Y. X. Yang, Hennessy, S., and Lewis, J. D., Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients, Gastroenterology, vol. 127, pp. 1044-50, 2004.
S. Hennessy, Bilker, W. B., Leonard, C. E., Chittams, J., Palumbo, C. M., Karlawish, J. H., Yang, Y. X., Lautenbach, E., Baine, W. B., and Metlay, J. P., Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures, J Clin Epidemiol, vol. 60, pp. 911-8, 2007.
L. V. Re, Carbonari, D. M., Saine, M. E., Newcomb, C. W., Roy, J. A., Liu, Q., Wu, Q., Cardillo, S., Haynes, K., Kimmel, S. E., Reese, P. P., Margolis, D. J., Apter, A. J., Reddy, K. R., Hennessy, S., Bhullar, H., Gallagher, A. M., Esposito, D. B., and Strom, B. L., Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes, BMJ Open Diabetes Res Care, vol. 5, p. e000400, 2017.
C. E. Leonard, Freeman, C. P., Newcomb, C. W., Reese, P. P., Herlim, M., Bilker, W. B., Hennessy, S., and Strom, B. L., Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury, Pharmacoepidemiol Drug Saf, vol. 21, pp. 1155-72, 2012.
A. J. Apter, Kinman, J. L., Bilker, W. B., Herlim, M., Margolis, D. J., Lautenbach, E., Hennessy, S., and Strom, B. L., Represcription of penicillin after allergic-like events, J Allergy Clin Immunol, vol. 113, pp. 764-70, 2004.
V. 3rd. Lo Re, Haynes, K., Ming, E. E., J. Ives, W., Horne, L. N., Fortier, K., Carbonari, D. M., Hennessy, S., Cardillo, S., Reese, P. P., Reddy, K. R., Margolis, D., Apter, A., Kimmel, S. E., Roy, J., Freeman, C. P., Razzaghi, H., Holick, C. N., Esposito, D. B., van Staa, T. P., Bhullar, H., and Strom, B. L., Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies, Pharmacoepidemiol Drug Saf, vol. 21, pp. 1202-15, 2012.
A. J. Apter, Kinman, J. L., Bilker, W. B., Herlim, M., Margolis, D. J., Lautenbach, E., Hennessy, S., and Strom, B. L., Is there cross-reactivity between penicillins and cephalosporins?, Am J Med, vol. 119, pp. 354.e11-9, 2006.
Y. X. Yang, Hennessy, S., and Lewis, J. D., Type 2 diabetes mellitus and the risk of colorectal cancer, Clin Gastroenterol Hepatol, vol. 3, pp. 587-94, 2005.
D. M. Carbonari, Saine, M. E., Newcomb, C. W., Blak, B., Roy, J. A., Haynes, K., Wood, J., Gallagher, A. M., Bhullar, H., Cardillo, S., Hennessy, S., Strom, B. L., and , Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN), Pharmacoepidemiol Drug Saf, vol. 24, pp. 999-1003, 2015.
[Page last reviewed 4 October 2019]